These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31275265)

  • 1. Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections.
    Behzadi MA; Leyva-Grado VH
    Front Microbiol; 2019; 10():1327. PubMed ID: 31275265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza, respiratory syncytial virus and SARS.
    Zambon M
    Medicine (Abingdon); 2005 May; 33(5):130-134. PubMed ID: 32308534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of common respiratory viruses and no evidence of Middle East respiratory syndrome coronavirus in Hajj pilgrims returning to Ghana, 2013.
    Annan A; Owusu M; Marfo KS; Larbi R; Sarpong FN; Adu-Sarkodie Y; Amankwa J; Fiafemetsi S; Drosten C; Owusu-Dabo E; Eckerle I
    Trop Med Int Health; 2015 Jun; 20(6):807-12. PubMed ID: 25688471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza, respiratory syncytial virus and SARS.
    Thompson C; Zambon M
    Medicine (Abingdon); 2009 Dec; 37(12):679-685. PubMed ID: 32288570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management.
    Hurt AC; Hui DS; Hay A; Hayden FG
    Influenza Other Respir Viruses; 2015 Jan; 9(1):20-31. PubMed ID: 25399715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influenza and other emerging respiratory viruses.
    Zambon M
    Medicine (Abingdon); 2014 Jan; 42(1):45-51. PubMed ID: 32288576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?
    Brooks MJ; Sasadeusz JJ; Tannock GA
    Curr Opin Pulm Med; 2004 May; 10(3):197-203. PubMed ID: 15071371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.
    Ascough S; Paterson S; Chiu C
    Front Immunol; 2018; 9():323. PubMed ID: 29552008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses.
    McKimm-Breschkin JL; Fry AM
    Antiviral Res; 2016 May; 129():21-38. PubMed ID: 26872862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.
    Wan H; Qi L; Gao J; Couzens LK; Jiang L; Gao Y; Sheng ZM; Fong S; Hahn M; Khurana S; Taubenberger JK; Eichelberger MC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference.
    McKimm-Breschkin JL; Jiang S; Hui DS; Beigel JH; Govorkova EA; Lee N
    Antiviral Res; 2018 Jan; 149():118-142. PubMed ID: 29162476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No MERS-CoV but positive influenza viruses in returning Hajj pilgrims, China, 2013-2015.
    Ma X; Liu F; Liu L; Zhang L; Lu M; Abudukadeer A; Wang L; Tian F; Zhen W; Yang P; Hu K
    BMC Infect Dis; 2017 Nov; 17(1):715. PubMed ID: 29126397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
    Han HJ; Liu JW; Yu H; Yu XJ
    Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape.
    Wang L; Shi W; Chappell JD; Joyce MG; Zhang Y; Kanekiyo M; Becker MM; van Doremalen N; Fischer R; Wang N; Corbett KS; Choe M; Mason RD; Van Galen JG; Zhou T; Saunders KO; Tatti KM; Haynes LM; Kwong PD; Modjarrad K; Kong WP; McLellan JS; Denison MR; Munster VJ; Mascola JR; Graham BS
    J Virol; 2018 May; 92(10):. PubMed ID: 29514901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus.
    Vergara-Alert J; Vidal E; Bensaid A; Segalés J
    One Health; 2017 Jun; 3():34-40. PubMed ID: 28616501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosides for the treatment of respiratory RNA virus infections.
    Jordan PC; Stevens SK; Deval J
    Antivir Chem Chemother; 2018; 26():2040206618764483. PubMed ID: 29562753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant.
    Hijano DR; Maron G; Hayden RT
    Front Microbiol; 2018; 9():3097. PubMed ID: 30619176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge.
    Nachbagauer R; Shore D; Yang H; Johnson SK; Gabbard JD; Tompkins SM; Wrammert J; Wilson PC; Stevens J; Ahmed R; Krammer F; Ellebedy AH
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29899095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel respiratory viruses: what should the clinician be alert for?
    Payne B; Bellamy R
    Clin Med (Lond); 2014 Dec; 14 Suppl 6():s12-6. PubMed ID: 25468912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging respiratory tract viral infections.
    Hui DS; Zumla A
    Curr Opin Pulm Med; 2015 May; 21(3):284-92. PubMed ID: 25764021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.